Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Currently approved anti-COVID-19 vaccines have been found to be safe and effective and almost 60% of Israeli residents are already vaccinated with BNT162b2 vaccine. This observational study was designed to evaluate the adverse events of vaccine reported by 61 healthcare workers at least 7 days after...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vaccine 2022-01, Vol.40 (3), p.428-431
Hauptverfasser:	Izak, Marina, Stoyanov, Evgeniy, Dezuraev, Keren, Shinar, Eilat
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-SARS-CoV-2 S1-specific IgG antibody levels BNT162 Vaccine COVID-19 COVID-19 Vaccines Female Health Personnel Humans Individuals presented with fever after vaccination had higher antibody levels Male Middle Aged RNA, Messenger SARS-CoV-2 Vaccination Vaccination with BNT162b2 mRNA COVID-19 Vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!